Prothena Corp Public (PRTA) Intangibles (2012 - 2013)
Prothena Corp Public's (PRTA) quarterly Intangibles came in at $44000.0 in Q1 2013, down 10.2% quarter-over-quarter from $49000.0 in Q4 2012.
Prothena Corp Public (PRTA) Intangibles (2012 - 2013) Analysis & Trends
Prothena Corp Public's Intangibles history runs 2 years deep, the most recent figure standing at $44000.0 for Q1 2013.
- On a quarterly basis, Intangibles changed N/A year-over-year to $44000.0 in Q1 2013; TTM through Mar 2013 was $44000.0, a N/A change from a year earlier, with the FY2012 full-year figure at $49000.0, changed N/A from the prior year.
- Intangibles fell to $44000.0 in Q1 2013 per PRTA's latest filing, from $49000.0 in the prior quarter.
- Across five years, Intangibles topped out at $49000.0 in Q4 2012 and bottomed at $44000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 55.80 Mn |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 44,000.00 |
| Dec 31, 2012 | 49,000.00 |